Key Announcement: Upcoming Board Meeting for Annual Results and Potential Dividend

Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has informed the market of an important upcoming event that may have a significant impact on shareholders and the company’s share price. The company’s Board of Directors will convene a meeting on Friday, 20 March 2026. The primary agenda items for this meeting include:

• Approval of the annual results for the year ended 31 December 2025 covering both the Company and its subsidiaries.
• Consideration of the payment of a final dividend (if any) for the financial year 2025.

Key Details for Investors

• The announcement of annual results is a potentially price-sensitive event as it will provide investors with critical insights into the company’s financial performance and outlook.
• The Board will also discuss the declaration of a final dividend. The payment or non-payment of a dividend can have a direct impact on shareholder value and may influence the company’s share price.
• Investors should be aware that the results, as well as any dividend announcement, are typically closely watched and can lead to increased trading activity and volatility in the share price.

Board Composition

The Board of Directors, as of the date of the announcement, comprises the following members:

• Executive Directors: Mr. Yan Han (Chairman), Mr. Yue Zheng (Vice Chairman), Mr. Wang Chi
• Non-executive Director: Ms. Feng Li
• Independent Non-executive Directors: Mr. Tsang Yok Sing, Jasper, Mr. Xu Hong Xi, Mr. Chan Ngai Chi

What Shareholders Need to Know

• The outcome of the Board meeting could have a direct impact on the company’s share price, depending on the financial results and dividend decision.
• Shareholders and potential investors should monitor the company’s disclosures closely around the date of the Board meeting (20 March 2026) for official announcements regarding the annual results and any dividend declaration.
• Any decision on dividends will affect the yield and may influence investment decisions regarding the stock.

In summary, the upcoming Board meeting represents a significant event for Beijing Tong Ren Tang Chinese Medicine Company Limited. Both the annual results and the potential dividend declaration are key events that could move the share price. Investors are advised to stay attentive to subsequent announcements from the company.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Shareholders and potential investors should consider their own risk tolerance and conduct their own due diligence before making any investment decisions. The actual results or dividend decision may differ from market expectations.

View TONGRENTANGCM Historical chart here